Model Information:

Middle lobe of liver: adenocarcinoma, cholangiocarcinoma on basis of IHC results, grade II-III. IHC results: Hepa(-), CK7(++), CK19(++), CD34(abundant blood sinus), CPC3(-), KI67(30%+), CD56(part +), CD117(-), HSP70(+), GS(scattered +), LCK(++).

Summary

Cancer TypeCholangiocarcinoma
SubtypeICC
GradeNA
StageNA
EthnicityAsian
GenderNA
AgeNA
Pathology Diagnosis

Middle lobe of liver: adenocarcinoma, cholangiocarcinoma on basis of IHC results, grade II-III. IHC results: Hepa(-), CK7(++), CK19(++), CD34(abundant blood sinus), CPC3(-), KI67(30%+), CD56(part +), CD117(-), HSP70(+), GS(scattered +), LCK(++).

Biopsy SiteLiver, middle lobe
Treatment HistoryNA
Pathology QCModerately differentiated adenocarcinoma (P7)
Special FeaturesPIK3CA E545K
Mouse StrainBalb/c nu
TMANA
PublicationNA

Growth Characteristics

Additional Characteristics